Study Shows Baricitinib Reduces Adult Atopic Dermatitis Severity Study Shows Baricitinib Reduces Adult Atopic Dermatitis Severity

Signs and symptoms of moderate to severe atopic dermatitis were significantly reduced with baricitinib 4 mg on top of topical corticosteroids, compared with placebo in the phase 3, BREEZE-AD7 study.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news